Researchers propose a novel closed-loop system merging brain-computer interfaces and peripheral nerve stimulation to enable real-time, adaptive therapy for neuropsychiatric disorders like depression and ADHD. This approach dynamically tailors treatment to individual brain signals, overcoming limitations of one-size-fits-all methods. The technology promises precision neuromodulation, targeting specific neural circuits without invasive surgery.

Mehdi Bennis, Professor at the University of Oulu Finland and leading researcher at 6G Flagship, has been named one of the world’s Highly Cited Researchers for the sixth year in a row. The annual recognition by Clarivate identifies researchers whose work has consistently shaped the direction of scientific progress, placing them among the top 1% most cited by field and publication year.

A research team in South Korea has successfully developed a novel technology that combines nanoparticles with stem cells to significantly improve 3D bone tissue regeneration. This advancement marks a major step forward in the treatment of bone fractures and injuries, as well as in next-generation regenerative medicine.

Dr. Ki Young Kim and her team at the Korea Research Institute of Chemical Technology (KRICT), in collaboration with Professor Laura Ha at Sunmoon University, have engineered a nanoparticle-stem cell hybrid, termed a nanobiohybrid by integrating mesoporous silica nanoparticles (mSiO₂ NPs) with human adipose-derived mesenchymal stem cells (hADMSCs). The resulting hybrid cells demonstrated markedly enhanced osteogenic (bone-forming) capability.